Company / EPS (Basic)
Progyny EPS (Basic) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.65
FY2025
5-year range
$0.33 / $0.74
FY2021-FY2025
Trend
+97.0%
vs FY2024
Sector context
#80 of 160
Health Care
What the data says
At $0.65, Progyny's eps (basic) ranks #80 of 160 in the Health Care sector. EPS (Basic) has fluctuated over the past 9 years, ranging from $-2.37 in FY2017 to $0.74 in FY2023.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of +3.8%.
Declined from $0.74 to $0.65 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
#80 of 160 in Health CareTop 50% of 160This company $0.65 Sector average $1.67
▼
-61.1% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 97.0% year-over-year.
- Ranks #80 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | +97.0% |
| FY2024 | $0.33 | -55.4% |
| FY2023 | $0.74 | +37.0% |
| FY2022 | $0.54 | -27.0% |
| FY2021 | $0.74 | +37.0% |
| FY2020 | $0.54 | +231.7% |
| FY2019 | -$0.41 | -1125.0% |
| FY2018 | $0.04 | +101.7% |
| FY2017 | -$2.37 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026